Impact Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
SMDAM
CRM
SW
Impact Capital Partners's AMGN Position: Q2 2026 in Review
Impact Capital Partners increased its Amgen (AMGN) stake by 0.35% in Q2 2026, buying an estimated $1.03K and bringing the position to 851 shares worth $308K. The position accounts for 0.08% of the portfolio, ranked #206.
Impact Capital Partners first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 830 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Impact Capital Partners held 851 shares of Amgen worth $308K as of Q2 2026.
- Impact Capital Partners bought 3 Amgen shares in Q2 2026, an estimated $1.03K.
- Amgen made up 0.08% of Impact Capital Partners's portfolio in Q2 2026, its #206 holding.
- Impact Capital Partners first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 830 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Impact Capital Partners's 13F filing for Q2 2026, filed 14 Jul 2026.